
Product News
Watchmaker Genomics and Revvity Team To Automate and Streamline NGS Library Preparation
Watchmaker Genomics has collaborated with Revvity to automate its DNA and RNA library preparation kits for NGS workflows on the Sciclone™ G3 NGSx platform.

Product News
Biodesix and Bio-Rad Drive Advances in ctDNA-Based Cancer Therapies
Biodesix, in partnership with Bio-Rad, contributed to the ctMoniTR Project, which demonstrated that changes in circulating tumor DNA (ctDNA) can predict cancer treatment outcomes.

Product News
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.

Product News
GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy
ProBioGen’s GlymaxX technology supports the FDA-approved Ziihera® antibody for HER2-positive biliary tract cancer, advancing targeted therapies.

Product News
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025
Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.

Product News
Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities
Dovetail Genomics, announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research.
Advertisement